AI-powered cardiac monitoring is evolving to address rising cardiovascular diseases
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Cardiac AI Monitoring And Diagnostics Market Progress Between 2026 And 2030?
The cardiac ai monitoring and diagnostics market size has experienced significant growth in recent years. It is forecast to increase from $2.14 billion in 2025 to $2.71 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 26.3%. Historically, this expansion has been propelled by factors such as the rising prevalence of cardiovascular diseases, improved availability of digital cardiac monitoring devices, increased utilization of ECG diagnostics in hospitals, the broadening of clinical cardiology services, and advancements in medical data analytics.
The cardiac AI monitoring and diagnostics market is projected to expand significantly in the coming years, reaching $6.94 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 26.5%. This anticipated growth is primarily due to the increasing adoption of AI-driven diagnostic tools, the rising demand for remote patient monitoring solutions, the expansion of personalized cardiac care, the growing integration of AI with imaging and biomarkers, and a greater emphasis on early disease detection. Key developments during this period will involve a greater uptake of AI-based ECG interpretation, the wider implementation of remote cardiac monitoring platforms, the increased application of predictive analytics in cardiology, the broadening availability of wearable AI-enabled cardiac devices, and improved integration of diverse cardiac data.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Factors Are Affecting The Cardiac AI Monitoring And Diagnostics Market Demand?
The increasing occurrence of cardiovascular diseases is anticipated to drive the expansion of cardiac AI monitoring and diagnostics in the future. Cardiovascular diseases (CVDs) encompass various conditions affecting the heart and blood vessels, such as cerebrovascular disease, coronary heart disease, and rheumatic heart disease, among others. Utilizing cardiac AI monitoring and diagnostics facilitates prompt diagnosis, accurate risk evaluation, and personalized treatment for cardiovascular ailments, ultimately leading to improved patient results. For example, data from the National Institutes of Health, a US-based government agency, in August 2025, indicates that from 2025 to 2050, cardiovascular prevalence is projected to rise by 90%, mortality by 73%, and DALYs by 55%, with deaths increasing from 20.5 million to 35.6 million. Consequently, the rising prevalence of cardiovascular diseases is a key driver for the cardiac AI monitoring and diagnostics market.
Which Segment Categories Are Included In The Cardiac AI Monitoring And Diagnostics Market Segment Analysis?
The cardiac ai monitoring and diagnostics market covered in this report is segmented –
1) By Function: Cardiac Diagnostics, Cardiac Monitoring
2) By Product: Software, Hardware
3) By Application: Ischemic Heart Diseases Or Coronary Artery Disease (CAD), Cardiac Arrhythmias
4) By End Users: Hospitals, Diagnostic Centers, Other End Users
Subsegments:
1) By Cardiac Diagnostics: ECG Analysis, Echocardiography Analysis, Cardiac Imaging
2) By Cardiac Monitoring: Wearable Cardiac Monitors, Remote Patient Monitoring Systems, Implantable Cardiac Devices, Continuous ECG Monitoring Systems
What Trends Are Influencing Changes In The Cardiac AI Monitoring And Diagnostics Market?
Leading companies in the cardiac AI monitoring and diagnostics market are prioritizing the development of technology-based medical devices, such as artificial intelligence-based implantable cardiac monitors, to solidify their market standing. These AI-powered implantable cardiac monitors are devices designed for continuous tracking of cardiac function. For instance, in May 2023, Biotronik, a Germany-based cardiovascular biomedical research and technology firm, announced the US Food and Drug Administration (FDA) had approved its BIOMONITOR IV implantable cardiac monitor (ICM). The BIOMONITOR IV implantable cardiac monitor (ICM) utilizes BIOTRONIK’s innovative, AI-powered SmartECG algorithm, which includes advanced algorithms that eliminate 86% of all false identifications while retaining 98% of real episodes. This revolutionary technology improves detection accuracy for healthcare professionals, reducing false positive alerts and helping them achieve prompt and precise diagnoses of specific cardiac issues. Beyond its SmartECG technology, BIOMONITOR IV is also the first ICM to distinguish between premature ventricular contractions (PVCs) and premature atrial contractions (PACs).
Who Are The Active Companies Shaping The Cardiac AI Monitoring And Diagnostics Market?
Major companies operating in the cardiac ai monitoring and diagnostics market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, ZOLL Medical Corporation, Canon Medical Systems Corporation, Biotronik SE & Co. KG, iRhythm Technologies Inc., Tempus Labs Inc., Viz.ai Inc., HeartFlow Inc., Aidoc, Eko Devices Inc., CardioFocus Inc., Circle Cardiovascular Imaging Inc., Ultromics Limited., Cathworks, Medicalgorithmics S.A., Nanox.AI Ltd, Cardiac Insight Inc., CardioSecur GmbH, Cardionomic Inc., HeartSciences, CardioComm Solutions Inc., CardioDiagnostics Inc.
Get The Full Cardiac AI Monitoring And Diagnostics Market Report:
Which Region Accounts For The Largest Portion Of The Cardiac AI Monitoring And Diagnostics Market?
North America was the largest region in the cardiac AI monitoring and diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac ai monitoring and diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Cardiac AI Monitoring And Diagnostics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Cardiac AI Monitoring And Diagnostics Market 2026, By The Business Research Company
Remote Cardiac Monitoring Market Report 2026
https://www.thebusinessresearchcompany.com/report/remote-cardiac-monitoring-global-market-report
Artificial Intelligence In Cardiology Market Report 2026
Ai In Medical Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
